Hello, Fool! | Login | Signup | My Fool
Jul 24, 2008 9:44 AM ET | Site Changes | Help
A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
View All Commentary (IMCL)
Recs
chelstad (< 20) Submitted: 9/11/07 2:36 PM : Start Price: $45.69 IMCL Score: 13.40
CEO bought in
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK